88 related articles for article (PubMed ID: 38500680)
1. Tuning of TRAIL clustering on the surface of nanoscale liposomes by phase separation.
Zhang Z; King MR
Nanoscale Adv; 2024 Jan; 6(2):402-405. PubMed ID: 38235079
[TBL] [Abstract][Full Text] [Related]
2. Beyond the danger signal: RNA aggregates orchestrate immunotherapy.
Shubhra QTH; Feczkó T; Cai Q
Trends Mol Med; 2024 Jun; ():. PubMed ID: 38866645
[TBL] [Abstract][Full Text] [Related]
3. Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
Razeghian E; Suksatan W; Sulaiman Rahman H; Bokov DO; Abdelbasset WK; Hassanzadeh A; Marofi F; Yazdanifar M; Jarahian M
Front Immunol; 2021; 12():699746. PubMed ID: 34489946
[TBL] [Abstract][Full Text] [Related]
4. Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy.
de Looff M; de Jong S; Kruyt FAE
Front Immunol; 2019; 10():1530. PubMed ID: 31333662
[TBL] [Abstract][Full Text] [Related]
5. Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression.
da Silva WN; Carvalho Costa PA; Scalzo Júnior SRA; Ferreira HAS; Prazeres PHDM; Campos CLV; Rodrigues Alves MT; Alves da Silva NJ; de Castro Santos AL; Guimarães LC; Chen Ferris ME; Thatte A; Hamilton A; Bicalho KA; Lobo AO; Santiago HDC; da Silva Barcelos L; Figueiredo MM; Teixeira MM; Vasconcelos Costa V; Mitchell MJ; Frézard F; Pires Goulart Guimaraes P
Int J Nanomedicine; 2024; 19():2655-2673. PubMed ID: 38500680
[TBL] [Abstract][Full Text] [Related]
6. Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis.
Gu T; Wang M; Fu X; Tian X; Bi J; Lu N; Chen C; Yan S; Li A; Wang L; Li X; Liu K; Dong Z
Biomed Pharmacother; 2024 May; 174():116603. PubMed ID: 38636395
[TBL] [Abstract][Full Text] [Related]
7. Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.
Oh Y; Swierczewska M; Kim TH; Lim SM; Eom HN; Park JH; Na DH; Kim K; Lee KC; Pomper MG; Lee S
J Control Release; 2015 Dec; 220(Pt B):671-81. PubMed ID: 26381901
[TBL] [Abstract][Full Text] [Related]
8. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy.
Jiang Y; Zhang Y; Liu C; Liu J; Xue W; Wang Z; Li X
J Control Release; 2024 Apr; 368():663-675. PubMed ID: 38492862
[TBL] [Abstract][Full Text] [Related]
9. Combined nano cancer immunotherapy based on immune status in a tumor microenvironment.
Nakamura T; Kawakami K; Nomura M; Sato Y; Hyodo M; Hatakeyama H; Hayakawa Y; Harashima H
J Control Release; 2022 May; 345():200-213. PubMed ID: 35307507
[TBL] [Abstract][Full Text] [Related]
10. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.
Naka T; Sugamura K; Hylander BL; Widmer MB; Rustum YM; Repasky EA
Cancer Res; 2002 Oct; 62(20):5800-6. PubMed ID: 12384541
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models.
Guimaraes LC; Costa PAC; Scalzo Júnior SRA; Ferreira HAS; Braga ACS; de Oliveira LC; Figueiredo MM; Shepherd S; Hamilton A; Queiroz-Junior CM; da Silva WN; da Silva NJA; Rodrigues Alves MT; Santos AK; de Faria KKS; Marim FM; Fukumasu H; Birbrair A; Teixeira-Carvalho A; de Aguiar RS; Mitchell MJ; Teixeira MM; Vasconcelos Costa V; Frezard F; Guimaraes PPG
Nat Commun; 2024 Jan; 15(1):590. PubMed ID: 38238326
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells.
Prazeres PHDM; Ferreira H; Costa PAC; da Silva W; Alves MT; Padilla M; Thatte A; Santos AK; Lobo AO; Sabino A; Del Puerto HL; Mitchell MJ; Guimaraes PPG
Int J Nanomedicine; 2023; 18():5891-5904. PubMed ID: 37873551
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.
Di Trani CA; Cirella A; Arrizabalaga L; Alvarez M; Bella Á; Fernandez-Sendin M; Russo-Cabrera JS; Gomar C; Ardaiz N; Teijeira A; Bolaños E; González-Gomariz J; Otano I; Aranda F; Palencia B; Segués A; Huang S; van Duijnhoven SMJ; van Elsas A; Melero I; Berraondo P
Mol Ther Nucleic Acids; 2023 Sep; 33():599-616. PubMed ID: 37637207
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
Han X; Alameh MG; Butowska K; Knox JJ; Lundgreen K; Ghattas M; Gong N; Xue L; Xu Y; Lavertu M; Bates P; Xu J; Nie G; Zhong Y; Weissman D; Mitchell MJ
Nat Nanotechnol; 2023 Sep; 18(9):1105-1114. PubMed ID: 37365276
[TBL] [Abstract][Full Text] [Related]
15. In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy.
Guimarães PPG; Figueroa-Espada CG; Riley RS; Gong N; Xue L; Sewastianik T; Dennis PS; Loebel C; Chung A; Shepherd SJ; Haley RM; Hamilton AG; El-Mayta R; Wang K; Langer R; Anderson DG; Carrasco RD; Mitchell MJ
Proc Natl Acad Sci U S A; 2023 Jun; 120(25):e2215711120. PubMed ID: 37310997
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
